{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Retinal+Disorder&page=62", "query": { "condition": "Retinal Disorder", "page": 62 }, "page_size": 10 }, "pagination": { "page": 62, "page_size": 10, "total_count": 1622, "total_pages": 163, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Retinal+Disorder&page=63&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Retinal+Disorder&page=61&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-10T09:29:24.272Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT06996080", "title": "A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Macular Edema Secondary to Inflammation" ], "interventions": [ { "name": "KSI-101", "type": "DRUG" }, { "name": "Sham Comparator", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Kodiak Sciences Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 300, "start_date": "2025-07-16", "completion_date": "2027-08", "has_results": false, "last_update_posted_date": "2026-05-18", "last_synced_at": "2026-11-10T09:29:24.272Z", "location_count": 55, "location_summary": "Phoenix, Arizona • Scottsdale, Arizona • Bakersfield, California + 47 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" }, { "city": "Glendale", "state": "California" }, { "city": "La Jolla", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06996080" }, { "nct_id": "NCT01783535", "title": "Protocol for the Study and Treatment of Participants With Intraocular Retinoblastoma", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Retinoblastoma" ], "interventions": [ { "name": "vincristine", "type": "DRUG" }, { "name": "topotecan", "type": "DRUG" }, { "name": "filgrastim", "type": "DRUG" }, { "name": "PEG-filgrastim", "type": "DRUG" }, { "name": "carboplatin", "type": "DRUG" }, { "name": "focal therapy", "type": "OTHER" }, { "name": "etoposide", "type": "DRUG" }, { "name": "cyclophosphamide", "type": "DRUG" }, { "name": "MESNA", "type": "DRUG" }, { "name": "doxorubicin", "type": "DRUG" }, { "name": "enucleation", "type": "PROCEDURE" }, { "name": "external beam radiation or proton beam radiation", "type": "RADIATION" } ], "intervention_types": [ "DRUG", "OTHER", "PROCEDURE", "RADIATION" ], "sponsor": "St. Jude Children's Research Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 174, "start_date": "2013-06-19", "completion_date": "2027-02-21", "has_results": true, "last_update_posted_date": "2026-06-29", "last_synced_at": "2026-11-10T09:29:24.272Z", "location_count": 1, "location_summary": "Memphis, Tennessee", "locations": [ { "city": "Memphis", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT01783535" }, { "nct_id": "NCT07330674", "title": "A Phase 1 Study of ABF-101 in Single- and Multiple-Ascending Doses", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Age Related Macular Degeneration (ARMD)", "AMD - Age-Related Macular Degeneration" ], "interventions": [ { "name": "ABF-101", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Aptabio Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 68, "start_date": "2026-02", "completion_date": "2027-12", "has_results": false, "last_update_posted_date": "2026-02-06", "last_synced_at": "2026-11-10T09:29:24.272Z", "location_count": 1, "location_summary": "Dallas, Texas", "locations": [ { "city": "Dallas", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07330674" }, { "nct_id": "NCT07891910", "title": "Iopidine to Decrease Intraocular Pressure Rise After Injections", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Macular Degeneration", "Diabetic Retinopathy", "Retinal Vein Occlusion", "Glaucoma" ], "interventions": [ { "name": "Apraclonidine 1.0% ophthalmic solution", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Retina Consultants of Delmarva", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 120, "start_date": "2026-10-01", "completion_date": "2027-01-01", "has_results": false, "last_update_posted_date": "2026-10-23", "last_synced_at": "2026-11-10T09:29:24.272Z", "location_count": 1, "location_summary": "Easton, Maryland", "locations": [ { "city": "Easton", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT07891910" }, { "nct_id": "NCT04704921", "title": "Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "AMD", "nAMD", "Wet Age-related Macular Degeneration", "wAMD", "Wet AMD", "CNV", "Neovascular AMD", "Neovascular Age-related Macular Degeneration", "Choroidal Neovascularization" ], "interventions": [ { "name": "ABBV-RGX-314", "type": "GENETIC" }, { "name": "Ranibizumab (LUCENTIS®)", "type": "BIOLOGICAL" } ], "intervention_types": [ "GENETIC", "BIOLOGICAL" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "89 Years", "sex": "ALL", "summary": "50 Years to 89 Years" }, "enrollment_count": 671, "start_date": "2020-12-29", "completion_date": "2027-11", "has_results": false, "last_update_posted_date": "2026-04-28", "last_synced_at": "2026-11-10T09:29:24.272Z", "location_count": 89, "location_summary": "Phoenix, Arizona • Sun City, Arizona • Little Rock, Arkansas + 77 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Sun City", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Campbell", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04704921" }, { "nct_id": "NCT07606365", "title": "A Study in Adults With Geographic Atrophy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Geographic Atrophy" ], "interventions": [ { "name": "STL303", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sitala Bio LTD", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "60 Years", "maximum_age": null, "sex": "ALL", "summary": "60 Years and older" }, "enrollment_count": 300, "start_date": "2026-09-11", "completion_date": "2029-08", "has_results": false, "last_update_posted_date": "2026-09-21", "last_synced_at": "2026-11-10T09:29:24.272Z", "location_count": 16, "location_summary": "Bakersfield, California • Beverly Hills, California • Aurora, Colorado + 12 more", "locations": [ { "city": "Bakersfield", "state": "California" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Waterford", "state": "Connecticut" }, { "city": "Lemont", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT07606365" }, { "nct_id": "NCT04919499", "title": "A Study of BI 765128 in Patients With an Eye Condition Called Diabetic Macular Ischemia Who Have Received Laser Treatment", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Diabetic Retinopathy" ], "interventions": [ { "name": "BI 765128", "type": "DRUG" }, { "name": "Sham comparator", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 46, "start_date": "2021-07-30", "completion_date": "2023-08-07", "has_results": true, "last_update_posted_date": "2024-11-21", "last_synced_at": "2026-11-10T09:29:24.272Z", "location_count": 11, "location_summary": "Bakersfield, California • Sacramento, California • Walnut Creek, California + 7 more", "locations": [ { "city": "Bakersfield", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Hagerstown", "state": "Maryland" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT04919499" }, { "nct_id": "NCT05961332", "title": "COmparison of Clarus and Optos Ultrawide Field Imaging Systems for Geographic Atrophy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Macular Degeneration, Age Related", "Geographic Atrophy" ], "interventions": [ { "name": "Spectralis FAF imaging", "type": "DEVICE" }, { "name": "Optos imaging", "type": "DEVICE" }, { "name": "Zeiss Clarus 700 imaging", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Wisconsin, Madison", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": null, "sex": "ALL", "summary": "50 Years and older" }, "enrollment_count": 62, "start_date": "2023-10-06", "completion_date": "2025-05-27", "has_results": true, "last_update_posted_date": "2026-07-10", "last_synced_at": "2026-11-10T09:29:24.272Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT05961332" }, { "nct_id": "NCT07519707", "title": "Video Intervention to Improve Understanding of Diabetic Retinopathy at Zuckerberg San Francisco General Hospital and Trauma Center", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Diabetic Retinopathy (DR)", "Macular Edema (ME)" ], "interventions": [ { "name": "Animated Videos", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 150, "start_date": "2026-09", "completion_date": "2027-12", "has_results": false, "last_update_posted_date": "2026-07-22", "last_synced_at": "2026-11-10T09:29:24.272Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07519707" }, { "nct_id": "NCT02229175", "title": "Laser vs Bevacizumab Injection Alone in Treatment of Diabetic Macular Edema", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Diabetic Macular Edema" ], "interventions": [ { "name": "bevacizumab", "type": "DRUG" }, { "name": "PASCAL Endpoint Management (EpM) laser treatment", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "University of California, San Francisco", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2021-01-01", "completion_date": "2027-01-01", "has_results": false, "last_update_posted_date": "2020-07-31", "last_synced_at": "2026-11-10T09:29:24.272Z", "location_count": 1, "location_summary": "San Francisco, California", "locations": [ { "city": "San Francisco", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02229175" } ] }